The UCSF CFAR Substance Use Program of Research (SUPR) and the Biomarkers of Behavior Sub-Core are hosting a networking lunch and featuring two speakers focused on substance use and HIV on January 18 from 12:30 - 3:30PM PT
Please join us!
Mission Hall
Networking Lunch 12:00PM-1:30PM PT (MH2100)
Presentations 1:30PM-3:30PM PT (MH2700 and virtual)
For more information and to RSVP, please contact Yvette Cuca (yvette.cuca@ucsf.edu).
Keynote: Robert Cook, MD, MPH
Clinical Trials of Alcohol Interventions in Persons with HIV: Our Experience with Prescription Medications and Contingency Management Using Biosensors
Robert Cook, MD, MPH
Professor, Department of Epidemiology,
University of Florida Health Internal Medicine
Dr. Robert Cook is a professor within the department of epidemiology, and he also serves as a physician at UF Health Internal Medicine – Medical Plaza. Dr. Cook received both his masters of public health degree and medical degree from the University of North Carolina. He interned in internal medicine at the University of Virginia before completing his residency in preventive medicine at the University of North Carolina. Upon completion of his residency, Dr. Cook concluded his fellowship training in preventive medicine with the Clinical Scholars Program. Dr. Cook has been at the University of Florida since 2006, combining clinical practice with research and teaching.
ESI Presentation: Ayesha Appa, MD
Combing through the data: what is the role of hair as a long-term biomarker of substance use in PLWH?
Ayesha Appa, MD
Assistant Professor, Division of HIV, ID, and Global Medicine
UC San Francisco
Dr. Ayesha Appa is an Assistant Professor in the Division of HIV, ID, and Global Medicine at UCSF. She graduated from UCSF with an MD with distinction, trained in Internal Medicine at the University of Washington, completed her chief residency at Harborview Medical Center, and completed both Infectious Diseases and Addiction Medicine fellowships at UCSF. Dr. Appa’s work has so far helped define gaps in effective care for people who have substance use disorders and HIV or other serious infections, and her research is now focused on the implementation of models that provide simultaneous treatment of substance use disorders and HIV or other serious infections. She works clinically at Ward 86 providing HIV primary care in the POP-UP and Women’s Clinic settings in addition to attending on the HIV/Infectious Diseases and Addiction Care Team inpatient consult teams at SFGH.